Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tamara Bozina"'
Autor:
Sandra Knežević, Francesca Filippi-Arriaga, Andrej Belančić, Tamara Božina, Jasenka Mršić-Pelčić, Dinko Vitezić
Publikováno v:
Diabetology, Vol 5, Iss 4, Pp 406-429 (2024)
Metabolic syndrome (MetS) presents a significant global health challenge, characterized by a cluster of metabolic alterations including obesity, hypertension, insulin resistance/dysglycemia, and atherogenic dyslipidemia. Advances in understanding and
Externí odkaz:
https://doaj.org/article/b85b61eae2e541988ee76497e910e49f
Autor:
Porin Makarić, Martina Rojnic Kuzman, Nikola Prpic, Dina Bošnjak Kuharić, Nada Bozina, Zarko Bajic, Tamara Bozina, Linda Rossini Gajsak, Lana Ganoci, Ivana Kekin
Publikováno v:
European Psychiatry. 61:88-96
INTRODUCTION: We analyzed the association of cannabinoid receptor CNR1 genotypes with changes in neurocognitive performance in patients with first-episode psychosis (FEP) after 18 months of treatment. Our secondary aim was to analyze the association
Autor:
Jure Samardzic, Marijan Pašalić, Mate Petricevic, Davor Miličić, Saša Pavasović, Tamara Bozina, Nada Bozina, Maja Čikeš, Lana Ganoci, Boško Skorić, Miroslav Krpan
Publikováno v:
Journal of cardiovascular pharmacology. 75(2)
Clopidogrel is still widely used in acute coronary syndrome despite the development of more potent P2Y12 inhibitors. Previously, we conducted a trial that evaluated serial clopidogrel dose adjustment based on platelet function testing in acute corona
Autor:
Dina Bošnjak Kuharić, Martina Rojnic Kuzman, Lana Ganoci, Ivana Kekin, Porin Makarić, Nikola Prpic, Tamara Bozina, Nada Bozina
Our aim was to analyze the association of HSPA1B genotypes and treatment response measured by the changes of psychopathology and neurocognitive symptoms in patients with first- episode psychosis (FEP) after 18 months of treatment. A sample of 159 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675f7f3e1a2af77feb5c59843c4b6d9b
https://www.bib.irb.hr/1070901
https://www.bib.irb.hr/1070901
Autor:
Jasna Lovrić, Ana Jelaković, Tamara Bozina, Livija Šimičević, J. Josipovic, Andrea Gelemanovic, B. Milicic, Dika Zivka, Sandra Karanović, Bojan Jelaković, Kresimir Djacic, V. Domislovic
Publikováno v:
Journal of Hypertension. 39:e264-e265
Autor:
null Petra, Martina Rojnic Kuzman, Porin Makaric, Dina Bosnjak Kuharic, Ivana Kekin, Linda Rossini Gajsak, Marina Boban, Nada Bozina, Tamara Bozina, Mirela Celic Ruzic, Sanja Darmopil, Igor Filipcic, Lana Ganoci, Ana Hladnik, Zoran Madzarac, Branko Malojcic, Alma Mihaljevic Peles, Daniel J. Mueller, Drazenka Ostojic, Zdravko Petanjek, Ratimir Petrovic, Zeljka Vogrinc, Aleksandar Savic, Ante Silic, Marina Sagud, Maja Zivkovic, Žarko Bajić
In this project, we recruited a sample of 150 patients with first episode of psychosis with schizophrenia features (FEP) and 100 healthy controls. We assessed the differences between these two groups, as well as the changes between the acute phase of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b9f9ed0d32b28e3d05b4c3121815a8b
https://doi.org/10.31219/osf.io/32dmr
https://doi.org/10.31219/osf.io/32dmr
Autor:
Dina, Bosnjak Kuharic, Nada, Bozina, Lana, Ganoci, Porin, Makaric, Ivana, Kekin, Nikola, Prpic, Tamara, Bozina, Martina, Rojnic Kuzman
Publikováno v:
The pharmacogenomics journal. 20(5)
Our aim was to analyze the association of HSPA1B genotypes and treatment response measured by the changes of psychopathology and neurocognitive symptoms in patients with first-episode psychosis (FEP) after 18 months of treatment. A sample of 159 pati
Autor:
Bojan Jelaković, L. Gellineo, Zivka Dika, Tamara Bozina, Vanja Ivković, V. Domislovic, Livija Šimičević, Mirjana Fuček, J. Josipovic, Jasna Lovrić, Ana Jelaković, B. Milicic, K. Djapic
Various environmental and endogenous factors (genetic predisposition) influence development of arterial hypertension (AH) and determine clinical course. The role of individual genes and their interactions with external factors is not yet elucidated.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d47d63dc4806eb40f005ce8ccd7576
https://doi.org/10.1097/01.hjh.0000572752.42097.45
https://doi.org/10.1097/01.hjh.0000572752.42097.45
Autor:
Zdravka Poljaković, Athanassios Vozikis, Nada Bozina, George P. Patrinos, Christina Mitropoulou, Ron H.N. van Schaik, Tamara Bozina, Svjetlana Šupe, Vasilios Fragoulakis
Publikováno v:
Pharmacogenomics, 16(2), 137-148. Future Medicine Ltd.
Background & methods: Economic evaluation in genomic medicine is an emerging discipline to assess the cost–effectiveness of genome-guided treatment. Here, we developed a pharmaco-economic model to assess whether pharmacogenomic (PGx)-guided warfari
Autor:
Tamara Božina, Lana Ganoci, Ena Karačić, Livija Šimičević, Majda Vrkić-Kirhmajer, Iva Klarica-Domjanović, Tena Križ, Zrinka Sertić, Nada Božina
Publikováno v:
Annals of Human Biology, Vol 49, Iss 7-8, Pp 323-331 (2022)
Background Organic anion-transporting polypeptide 1B1 (OATP1B1) and the ATP-binding cassette subfamily G member 2, ABCG2, are important transporters involved in the transport of endogenous substrates and xenobiotics, including drugs. Genetic polymorp
Externí odkaz:
https://doaj.org/article/ba302c8799c148b68bd254980828ad93